Inspire Medical Systems, Inc. Capital Expenditures
Inspire Medical Systems, Inc. (INSP) reported Capital Expenditures of $18.89 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-03
- Inspire Medical Systems, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $9.16M, a 1.81% increase year-over-year.
- Inspire Medical Systems, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $9.73M, a 15.69% increase year-over-year.
- Inspire Medical Systems, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $10.66M, a 51.64% increase year-over-year.
- Inspire Medical Systems, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $10.44M, a 30.37% increase year-over-year.
- Inspire Medical Systems, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $38.50M, a 1.59% decline from fiscal 2024.
- Inspire Medical Systems, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $39.12M, a 65.57% increase from fiscal 2023.
- Inspire Medical Systems, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $23.63M, a 159.77% increase from fiscal 2022.
- Inspire Medical Systems, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $9.10M, a 94.86% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $9.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $18.89M 10-Q · filed 2026-08-03 | $29.54M derived: sum of 3 quarters · filed 2026-08-03 | $39.98M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $9.73M 10-Q · filed 2026-05-04 | $20.38M derived: sum of 2 quarters · filed 2026-05-04 | $30.82M derived: sum of 3 quarters · filed 2026-05-04 | $39.82M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $10.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $21.09M derived: sum of 2 quarters · filed 2026-02-13 | $30.09M derived: sum of 3 quarters · filed 2026-08-03 | $38.50M 10-K · filed 2026-02-13 |
| 2025-09-30 | $10.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $19.44M derived: sum of 2 quarters · filed 2026-08-03 | $27.84M 10-Q · filed 2025-11-03 | $34.87M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $9.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $17.40M 10-Q · filed 2026-08-03 | $24.43M derived: sum of 3 quarters · filed 2026-08-03 | $32.44M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $8.41M 10-Q · filed 2026-05-04 | $15.43M derived: sum of 2 quarters · filed 2026-05-04 | $23.44M derived: sum of 3 quarters · filed 2026-05-04 | $35.83M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $7.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $15.03M derived: sum of 2 quarters · filed 2026-02-13 | $27.43M derived: sum of 3 quarters · filed 2026-02-13 | $39.12M 10-K · filed 2026-02-13 |
| 2024-09-30 | $8.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $20.40M derived: sum of 2 quarters · filed 2025-11-03 | $32.10M 10-Q · filed 2025-11-03 | $40.13M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $12.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $24.09M 10-Q · filed 2025-08-04 | $32.12M derived: sum of 3 quarters · filed 2026-02-13 | $39.11M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $11.70M 10-Q · filed 2025-05-05 | $19.73M derived: sum of 2 quarters · filed 2026-02-13 | $26.72M derived: sum of 3 quarters · filed 2026-02-13 | $31.57M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $8.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $15.02M derived: sum of 2 quarters · filed 2026-02-13 | $19.88M derived: sum of 3 quarters · filed 2026-02-13 | $23.63M 10-K · filed 2026-02-13 |
| 2023-09-30 | $6.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $11.84M derived: sum of 2 quarters · filed 2024-11-04 | $15.60M 10-Q · filed 2024-11-04 | $18.55M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-06-30 | $4.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $8.61M 10-Q · filed 2024-08-06 | $11.56M derived: sum of 3 quarters · filed 2025-02-10 | $15.07M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-03-31 | $3.75M 10-Q · filed 2024-05-07 | $6.70M derived: sum of 2 quarters · filed 2025-02-10 | $10.21M derived: sum of 3 quarters · filed 2025-02-10 | $11.63M derived: sum of 4 quarters · filed 2025-02-10 |
| 2022-12-31 | $2.95M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | $6.46M derived: sum of 2 quarters · filed 2025-02-10 | $7.88M derived: sum of 3 quarters · filed 2025-02-10 | $9.10M 10-K · filed 2025-02-10 |
| 2022-09-30 | $3.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $4.93M derived: sum of 2 quarters · filed 2023-11-07 | $6.15M 10-Q · filed 2023-11-07 | $6.68M derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-06-30 | $1.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $2.63M 10-Q · filed 2023-08-01 | $3.17M derived: sum of 3 quarters · filed 2024-02-09 | $4.32M derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-03-31 | $1.22M 10-Q · filed 2023-05-02 | $1.75M derived: sum of 2 quarters · filed 2024-02-09 | $2.90M derived: sum of 3 quarters · filed 2024-02-09 | $4.56M derived: sum of 4 quarters · filed 2024-02-09 |
| 2021-12-31 | $533.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | $1.68M derived: sum of 2 quarters · filed 2024-02-09 | $3.35M derived: sum of 3 quarters · filed 2024-02-09 | $4.67M 10-K · filed 2024-02-09 |
| 2021-09-30 | $1.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $2.81M derived: sum of 2 quarters · filed 2022-11-01 | $4.13M 10-Q · filed 2022-11-01 | $4.74M derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-06-30 | $1.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $2.98M 10-Q · filed 2022-08-02 | $3.59M derived: sum of 3 quarters · filed 2023-02-10 | $4.80M derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-03-31 | $1.32M 10-Q · filed 2022-05-03 | $1.93M derived: sum of 2 quarters · filed 2023-02-10 | $3.14M derived: sum of 3 quarters · filed 2023-02-10 | $3.52M derived: sum of 4 quarters · filed 2023-02-10 |
| 2020-12-31 | $604.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $1.82M derived: sum of 2 quarters · filed 2023-02-10 | $2.20M derived: sum of 3 quarters · filed 2023-02-10 | $2.46M 10-K · filed 2023-02-10 |
| 2020-09-30 | $1.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $1.60M derived: sum of 2 quarters · filed 2021-11-02 | $1.85M 10-Q · filed 2021-11-02 | $2.29M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | $381.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $636.00K 10-Q · filed 2021-08-03 | $1.08M derived: sum of 3 quarters · filed 2022-02-15 | $2.14M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | $255.00K 10-Q · filed 2021-05-04 | $697.00K derived: sum of 2 quarters · filed 2022-02-15 | $1.76M derived: sum of 3 quarters · filed 2022-02-15 | $2.72M derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | $442.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $1.51M derived: sum of 2 quarters · filed 2022-02-15 | $2.46M derived: sum of 3 quarters · filed 2022-02-15 | $2.74M 10-K · filed 2022-02-15 |
| 2019-09-30 | $1.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $2.02M derived: sum of 2 quarters · filed 2020-11-02 | $2.30M 10-Q · filed 2020-11-02 | $2.49M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $958.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $1.23M 10-Q · filed 2020-08-04 | $1.42M derived: sum of 3 quarters · filed 2021-02-24 | $1.42M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $275.00K 10-Q · filed 2020-05-05 | $466.00K derived: sum of 2 quarters · filed 2021-02-24 | $466.00K derived: sum of 3 quarters · filed 2021-02-24 | $518.00K derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $191.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $191.00K derived: sum of 2 quarters · filed 2021-02-24 | $243.00K derived: sum of 3 quarters · filed 2021-02-24 | $250.00K 10-K · filed 2021-02-24 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $52.00K derived: sum of 2 quarters · filed 2019-11-05 | $59.00K 10-Q · filed 2019-11-05 | $121.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $52.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $59.00K 10-Q · filed 2019-08-06 | $121.00K derived: sum of 3 quarters · filed 2020-02-25 | $245.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $7.00K 10-Q · filed 2019-05-07 | $69.00K derived: sum of 2 quarters · filed 2020-02-25 | $193.00K derived: sum of 3 quarters · filed 2020-02-25 | $213.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $62.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $186.00K derived: sum of 2 quarters · filed 2020-02-25 | $206.00K derived: sum of 3 quarters · filed 2020-02-25 | $412.00K 10-K · filed 2020-02-25 |
| 2017-09-30 | $124.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $144.00K derived: sum of 2 quarters · filed 2018-11-06 | $350.00K 10-Q · filed 2018-11-06 | |
| 2017-06-30 | $20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $226.00K 10-Q · filed 2018-08-07 | ||
| 2017-03-31 | $206.00K 10-Q · filed 2018-06-07 | |||
| 2016-12-31 | $306.00K 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |